50 results on '"Chaisson, Richard E"'
Search Results
2. Completion, safety, and efficacy of tuberculosis preventive treatment regimens containing rifampicin or rifapentine: an individual patient data network meta-analysis
3. Tuberculosis screening among ambulatory people living with HIV: a systematic review and individual participant data meta-analysis
4. Systemic DPP4/CD26 is associated with natural HIV-1 control: Implications for COVID-19 susceptibility
5. Human leukocyte antigen associations with protection against tuberculosis infection and disease in human immunodeficiency virus-1 infected individuals, despite household tuberculosis exposure and immune suppression
6. Cost-effectiveness of scaling up short course preventive therapy for tuberculosis among children across 12 countries
7. The impact of bone marrow stromal antigen-2 (BST2) gene variants on HIV-1 control in black South African individuals
8. Once-weekly rifapentine and isoniazid for tuberculosis prevention in patients with HIV taking dolutegravir-based antiretroviral therapy: a phase 1/2 trial
9. High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trial
10. A Partially-Randomised Phase 3 Trial of Pretomanid, Moxifloxacin and Pyrazinamide in Combination for the Treatment of Drug-Susceptible and Drug-Resistant Pulmonary Tuberculosis
11. High prevalence of rifampin-resistant tuberculosis in mountainous districts of India
12. Cis-regulatory genetic variants in the CCR5 gene and natural HIV-1 control in black South Africans
13. Preventing tuberculosis in people with HIV—no more excuses
14. CXCR6 gene characterization in two ethnically distinct South African populations and association with viraemic disease control in HIV-1-infected black South African individuals
15. RICH2 is implicated in viraemic control of HIV-1 in black South African individuals
16. Controlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infection
17. Survival of HIV patients with tuberculosis started on simultaneous or deferred HAART in the THRio cohort, Rio de Janeiro, Brazil
18. Reply to “At the crossroads between early or delayed antiretroviral therapy initiation during TB/HIV coinfection”
19. Taking the long view on the CREATE studies' findings
20. Effect of improved tuberculosis screening and isoniazid preventive therapy on incidence of tuberculosis and death in patients with HIV in clinics in Rio de Janeiro, Brazil: a stepped wedge, cluster-randomised trial
21. Human Immunodeficiency Virus–Associated Tuberculosis
22. Physician adherence to guidelines for tuberculosis and HIV care in Rio de Janeiro, Brazil
23. Thibela TB: Design and methods of a cluster randomised trial of the effect of community-wide isoniazid preventive therapy on tuberculosis amongst gold miners in South Africa
24. Point-of-care Arkansas method for measuring adherence to treatment with isoniazid
25. Tuberculosis and diabetes mellitus: convergence of two epidemics
26. Moxifloxacin versus ethambutol in initial tuberculosis treatment – Authors' reply
27. Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial
28. Non-tuberculous mycobacteria in HIV-infected patients: geographic, behavioural, and immunological factors – Authors' reply
29. Mycobacterium avium complex in patients with HIV infection in the era of highly active antiretroviral therapy
30. Opioid detoxification with buprenorphine, clonidine, or methadone in hospitalized heroin-dependent patients with HIV infection
31. Paradoxical Worsening of Tuberculosis in HIV-Infected Persons
32. A randomized, controlled trial of interventions to improve adherence to isoniazid therapy to prevent tuberculosis in injection drug users
33. Why Blame Private Practitioners?
34. Errors in the Treatment of Tuberculosis in Baltimore
35. Lack of sex difference in CD4 to HIV-1 RNA viral load ratio
36. The Effect of Adjunctive Corticosteroids for the Treatment of Pneumocystis carinii Pneumonia on Mortality and Subsequent Complications
37. Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection
38. SHORT-COURSE CHEMOPROPHYLAXIS FOR TUBERCULOSIS
39. Adverse Events from Drug Therapy for Human Immunodeficiency Virus Disease
40. Tuberculin skin test reactivity, anergy, and HIV infection in hospitalized patients
41. The Effect of Prophylaxis on the Outcome of HIV-Associated Pneumocystis carinii Pneumonia
42. The Impact of Prophylaxis on Outcome and Resource Utilization in Pneumocystis carinii Pneumonia
43. Adverse Reactions to Therapy for HIV Infection
44. Health Effects and Exposure Assessment of Aerosolized Pentamidine Handlers
45. Prevalence and incidence of left ventricular dysfunction in patients with human immunodeficiency virus infection
46. Vitamin A status in HIV infection
47. Efficacy of Engineering Controls in Reducing Occupational Exposure to Aerosolized Pentamidine
48. Acute effects of a nucleoside analog dideoxyinosine (DDI) on the pancreas
49. Rectal leishmaniasis in a patient with acquired immunodeficiency syndrome
50. Infections Due to Encapsulated Bacteria, Salmonella, Shigella, and Campylobacter
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.